|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
25,920,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with gastrointestinal, or GI, diseases. Co.'s program, MET642, targets the farnesoid X receptor, or FXR, which is central to modulating GI and liver diseases. Co. is developing another FXR agonist, MET409, for the treatment of non-alcoholic steatohepatitis, or NASH, a liver disease characterized by excess liver fat, inflammation and fibrosis. Co. is also developing small molecule inhibitors of hydroxysteroid dehydrogenase 17b13, or HSD17ss13, for the treatment of NASH. HSD17ss13 is a genetically validated target for liver disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,510,570 |
| Total Buy Value |
$0 |
$0 |
$0 |
$936,096 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
487,659 |
| Total Sell Value |
$0 |
$0 |
$0 |
$201,597 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Klassen Preston |
Director |
– • – |
2023-03-23 |
4 |
A |
$0.47 |
$395,839 |
D/D |
842,211 |
1,384,116 |
|
- |
|
| Klassen Preston |
President & CEO |
• • – |
2023-01-26 |
4 |
S |
$0.41 |
$157,266 |
D/D |
(380,605) |
541,905 |
|
- |
|
| York Michael |
Chief Business Officer |
• – – |
2023-01-26 |
4 |
S |
$0.41 |
$44,331 |
D/D |
(107,054) |
103,499 |
|
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-12-21 |
4 |
B |
$0.40 |
$48,040 |
I/I |
120,099 |
6,160,570 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-12-20 |
4 |
B |
$0.38 |
$19,001 |
I/I |
50,122 |
6,040,471 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-12-19 |
4 |
B |
$0.40 |
$40,554 |
I/I |
101,384 |
5,990,349 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-11-09 |
4 |
B |
$0.39 |
$15,528 |
I/I |
39,816 |
5,888,965 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-11-08 |
4 |
B |
$0.40 |
$200 |
I/I |
500 |
5,849,149 |
1.42 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-11-07 |
4 |
B |
$0.42 |
$52,346 |
I/I |
123,954 |
5,848,649 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-10-28 |
4 |
B |
$0.40 |
$18,000 |
I/I |
45,022 |
5,724,695 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-10-27 |
4 |
B |
$0.39 |
$299,328 |
I/I |
767,507 |
5,679,673 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-10-26 |
4 |
B |
$0.35 |
$208,223 |
I/I |
588,533 |
4,912,166 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-10-25 |
4 |
B |
$0.35 |
$175,596 |
I/I |
499,279 |
4,323,633 |
1.5 |
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-10-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
600,000 |
|
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,824,354 |
|
- |
|
| Leonard Braden Michael |
10% Owner |
– – • |
2022-10-24 |
4 |
B |
$0.34 |
$59,280 |
I/I |
174,354 |
3,824,354 |
1.5 |
- |
|
| Klassen Preston |
President & CEO |
• • – |
2022-04-19 |
4 |
S |
$0.50 |
$22,472 |
D/D |
(44,748) |
922,510 |
|
- |
|
| Klassen Preston |
President & CEO |
• • – |
2022-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
104,500 |
967,258 |
|
- |
|
| Klassen Preston |
President & CEO |
• • – |
2022-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
842,211 |
862,758 |
|
- |
|
| York Michael |
Chief Business Officer |
• – – |
2022-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
210,553 |
210,553 |
|
- |
|
| Behbahani Ali |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
|
- |
|
| Chang Carmen |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
|
- |
|
| Makhzoumi Mohamad |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
|
- |
|
| Sonsini Peter W. |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
|
- |
|
84 Records found
|
|
Page 1 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
